标题
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
作者
关键词
-
出版物
BIODRUGS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-07
DOI
10.1007/s40259-019-00370-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Guide to PIN1 Function and Mutations Across Cancers
- (2019) Maguie El Boustani et al. Frontiers in Pharmacology
- Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression
- (2019) Chun-Yu Liu et al. EBioMedicine
- Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
- (2019) Marie-Eve Beaulieu et al. Science Translational Medicine
- Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status
- (2019) Davood Bashash et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities
- (2019) Andrea Bisso et al. IMMUNOLOGICAL REVIEWS
- SF2523 inhibits human chondrosarcoma cell growth in vitro and in vivo
- (2019) Jia-Xue Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer
- (2019) Ion Cristóbal et al. Journal of Clinical Medicine
- Dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth in vitro and in vivo
- (2018) Gang Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- AZD5153, a novel BRD4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo
- (2018) Kun Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach
- (2018) Loana Musso et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Small Molecule Driven Stabilization of Promoter G-Quadruplexes and Transcriptional Regulation of c-MYC
- (2018) Tania Das et al. BIOCONJUGATE CHEMISTRY
- HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc
- (2018) Huawei Qu et al. BIOMEDICINE & PHARMACOTHERAPY
- Synergistic activity of BET inhibitor BI 894999 with PLK inhibitor volasertib in AML in vitro and in vivo
- (2018) Ulrike Tontsch-Grunt et al. CANCER LETTERS
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- A complex of the ubiquitin ligase TRIM32 and the deubiquitinase USP7 balances the level of c-Myc ubiquitination and thereby determines neural stem cell fate specification
- (2018) Sarah Nicklas et al. CELL DEATH AND DIFFERENTIATION
- Therapeutic targeting of PP2A
- (2018) Caitlin M. O’Connor et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2
- (2018) Tomoko Takimoto-Shimomura et al. INVESTIGATIONAL NEW DRUGS
- Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
- (2018) Grant R. Campbell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways
- (2018) Dayun Yang et al. JOURNAL OF CONTROLLED RELEASE
- Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex
- (2018) Ming-Hao Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Intrinsically Disordered Transcription Factors: Changing the Paradigm
- (2018) K. Tsafou et al. JOURNAL OF MOLECULAR BIOLOGY
- OUP accepted manuscript
- (2018) NUCLEIC ACIDS RESEARCH
- Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
- (2018) Sara Bolin et al. ONCOGENE
- The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
- (2018) Daniel Gerlach et al. ONCOGENE
- PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
- (2018) Otto Kauko et al. Science Translational Medicine
- Targeting deubiquitinase USP28 for cancer therapy
- (2018) Xiaofang Wang et al. Cell Death & Disease
- Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
- (2018) Lingdi Zhang et al. Nature Communications
- A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
- (2018) Alina Castell et al. Scientific Reports
- Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas
- (2018) Franz X. Schaub et al. Cell Systems
- CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
- (2018) Xu-hong Fu et al. ACTA PHARMACOLOGICA SINICA
- c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression
- (2018) Merve Aksoz et al. CURRENT CANCER DRUG TARGETS
- Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models
- (2018) Hongmei Jiang et al. MOLECULAR CANCER THERAPEUTICS
- Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers
- (2018) Edina Wang et al. ONCOGENE
- c-Myc is a major determinant for antitumor activity of Aurora A kinase inhibitor MLN8237 in thyroid cancer
- (2018) Yiqi Li et al. THYROID
- Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
- (2018) Tyler Risom et al. Nature Communications
- An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity
- (2018) Naoya Ieda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma
- (2018) Brittany L. Allen-Petersen et al. CANCER RESEARCH
- Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals
- (2018) Yulong Su et al. GENES & DEVELOPMENT
- Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
- (2018) Lavinia Carabet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SUMO protease SENP1 deSUMOylates and stabilizes c-Myc
- (2018) Xiao-Xin Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
- (2018) David R. Calabrese et al. Nature Communications
- OP449 inhibits breast cancer growth without adverse metabolic effects
- (2017) Gadi Shlomai et al. ENDOCRINE-RELATED CANCER
- EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells
- (2017) Chun-Yu Liu et al. EUROPEAN JOURNAL OF CANCER
- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- Exploiting Epigenetic Alterations in Prostate Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells
- (2017) Dongyeon Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
- (2017) Jaya Sangodkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway
- (2017) Jinhui Wu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- FTY720/fingolimod, an oral S1PR modulator, mitigates radiation induced cognitive deficits
- (2017) Alexander M. Stessin et al. NEUROSCIENCE LETTERS
- Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4
- (2017) X Hu et al. ONCOGENE
- Small molecule selectively suppresses MYC transcription in cancer cells
- (2017) Claire Bouvard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dual-activity PI3K–BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis
- (2017) Forest H. Andrews et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
- (2017) Amy S. Farrell et al. Nature Communications
- A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action
- (2017) Elena Campaner et al. Nature Communications
- Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
- (2017) Alfonso Urbanucci et al. Cell Reports
- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
- (2017) Yasuhiro Oki et al. HAEMATOLOGICA
- MYC Deregulation in Primary Human Cancers
- (2017) Manpreet Kalkat et al. Genes
- MYC—Master Regulator of the Cancer Epigenome and Transcriptome
- (2017) Candace J. Poole et al. Genes
- Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
- (2016) Markus Brockmann et al. CANCER CELL
- Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression
- (2016) Tikvah K. Hayes et al. CANCER CELL
- Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review
- (2016) Ion Cristóbal et al. CURRENT MEDICAL RESEARCH AND OPINION
- HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation
- (2016) Kevin B Myant et al. EMBO Molecular Medicine
- Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts
- (2016) Ramiro Vázquez et al. INTERNATIONAL JOURNAL OF CANCER
- Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
- (2016) Xiaoguang Fang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)
- (2016) Robert H. Bradbury et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Mechanosensor Mechanism Controls the G-Quadruplex/i-Motif Molecular Switch in the MYC Promoter NHE III1
- (2016) Caleb Sutherland et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation
- (2016) A N McCracken et al. LEUKEMIA
- Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
- (2016) Kaiming Sun et al. MOLECULAR CANCER THERAPEUTICS
- Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma
- (2016) A. R. Singh et al. MOLECULAR CANCER THERAPEUTICS
- AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies
- (2016) G. W. Rhyasen et al. MOLECULAR CANCER THERAPEUTICS
- HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
- (2016) Omid Tavana et al. NATURE MEDICINE
- A MYC–aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
- (2016) Daniel Dauch et al. NATURE MEDICINE
- OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors
- (2016) L A Jung et al. ONCOGENE
- The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
- (2016) L L da Motta et al. ONCOGENE
- OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations
- (2016) Maria E. Riveiro et al. Oncotarget
- Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
- (2016) Wohn-Jenn Leu et al. Oncotarget
- MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells
- (2016) Fuyumi Kato et al. Oncotarget
- Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc
- (2016) Luana D’Artista et al. Oncotarget
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
- (2016) Céline Berthon et al. Lancet Haematology
- Myc and its interactors take shape
- (2015) William B. Tu et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma
- (2015) Meng Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
- (2015) Smita Matkar et al. CANCER CELL
- All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase
- (2015) Jaya Sangodkar et al. FEBS Journal
- Effect of Pin1 inhibitor juglone on proliferation, migration and angiogenic ability of breast cancer cell line MCF7Adr
- (2015) Yuan-gui Hu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
- (2015) Dharmendra Dingar et al. Journal of Proteomics
- The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma
- (2015) Shuhei ENJOJI et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
- (2015) Shuo Wei et al. NATURE MEDICINE
- Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines
- (2015) Ryuhei Kanaoka et al. PLoS One
- Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity
- (2015) Sara Helander et al. STRUCTURE
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
- (2015) Marie-Magdelaine Coudé et al. Oncotarget
- Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis
- (2015) Xiaoyong Hu et al. Scientific Reports
- PP2A: The Wolf in Sheep’s Clothing?
- (2015) Maeve Kiely et al. Cancers
- Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
- (2015) Ho Kyung Seo et al. Oncotarget
- Disruption of Myc-Max Heterodimerization with Improved Cell-Penetrating Analogs of the Small Molecule 10074-G5
- (2015) Huabo Wang et al. Oncotarget
- Prolyl isomerase Pin1 in cancer
- (2014) Zhimin Lu et al. CELL RESEARCH
- SETting OP449 into the PP2A-Activating Drug Family
- (2014) P. Neviani et al. CLINICAL CANCER RESEARCH
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
- (2014) S. Peter et al. EMBO Molecular Medicine
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
- (2014) Chun-Hao Huang et al. GENES & DEVELOPMENT
- Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
- (2014) Alejandro Gutierrez et al. JOURNAL OF CLINICAL INVESTIGATION
- Inactivation of MYC reverses tumorigenesis
- (2014) Y. Li et al. JOURNAL OF INTERNAL MEDICINE
- Therapeutic Effects of an Anti-Myc Drug on Mouse Pancreatic Cancer
- (2014) Dimitris Stellas et al. JNCI-Journal of the National Cancer Institute
- Efficacy of cyclin-dependent-kinase 9 inhibitors in a murine model of mixed-lineage leukemia
- (2014) M-P Garcia-Cuellar et al. LEUKEMIA
- Targeting Inhibitors of the Tumor Suppressor PP2A for the Treatment of Pancreatic Cancer
- (2014) Amy S. Farrell et al. MOLECULAR CANCER RESEARCH
- Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
- (2014) Arianna Sabò et al. NATURE
- Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
- (2014) Susanne Walz et al. NATURE
- USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
- (2014) J Pan et al. ONCOGENE
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
- (2014) Joydeep Bhadury et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitor of MYC identified in a Krohnke pyridine library
- (2014) J. R. Hart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A
- (2014) H-C Yu et al. Cell Death & Disease
- Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
- (2014) Daniela Annibali et al. Nature Communications
- MYC Degradation
- (2014) A. S. Farrell et al. Cold Spring Harbor Perspectives in Medicine
- Genome Recognition by MYC
- (2014) A. Sabo et al. Cold Spring Harbor Perspectives in Medicine
- An Overview of MYC and Its Interactome
- (2014) M. Conacci-Sorrell et al. Cold Spring Harbor Perspectives in Medicine
- Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
- (2013) Jonathan D. Moore et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- Cancerous inhibitor of PP2A is targeted by natural compound celastrol for degradation in non-small-cell lung cancer
- (2013) Zi Liu et al. CARCINOGENESIS
- Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
- (2013) B. Li et al. CLINICAL CANCER RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
- (2013) L. Soucek et al. GENES & DEVELOPMENT
- Intravesical Instillation of c-MYC Inhibitor KSI-3716 Suppresses Orthotopic Bladder Tumor Growth
- (2013) Kyung-Chae Jeong et al. JOURNAL OF UROLOGY
- Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis
- (2013) A. S. Farrell et al. MOLECULAR AND CELLULAR BIOLOGY
- MYC-y mice: From tumour initiation to therapeutic targeting of endogenous MYC
- (2013) Jennifer P. Morton et al. Molecular Oncology
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- MYC activity is negatively regulated by a C-terminal lysine cluster
- (2013) A R Wasylishen et al. ONCOGENE
- Thermally Targeted Delivery of a c-Myc Inhibitory Polypeptide Inhibits Tumor Progression and Extends Survival in a Rat Glioma Model
- (2013) Gene L. Bidwell et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
- (2013) E. J. Morris et al. Cancer Discovery
- Pharmacophore identification of c-Myc inhibitor 10074-G5
- (2012) Jeremy L. Yap et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
- (2012) H. Kantarjian et al. BLOOD
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
- (2012) Dai Horiuchi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
- (2012) M Niemelä et al. ONCOGENE
- Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression
- (2012) Weiwei Huang et al. PLoS One
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland
- (2011) X. Wang et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Endogenous Myc maintains the tumor microenvironment
- (2011) N. M. Sodir et al. GENES & DEVELOPMENT
- Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia
- (2011) I. Cristobal et al. HAEMATOLOGICA
- Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma
- (2011) Hany A. Omar et al. HEPATOLOGY
- Demonstration that Drug-targeted Down-regulation of MYC in Non-Hodgkins Lymphoma Is Directly Mediated through the Promoter G-quadruplex
- (2011) Robert V. Brown et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-MYC promoter G-quadruplex formed at the 5′-end of NHE III 1 element: insights into biological relevance and parallel-stranded G-quadruplex stability
- (2011) Raveendra I. Mathad et al. NUCLEIC ACIDS RESEARCH
- Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression
- (2011) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The C-Terminus of Nucleolin Promotes the Formation of the c-MYCG-Quadruplex and Inhibits c-MYCPromoter Activity
- (2010) Verónica González et al. BIOCHEMISTRY
- A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- Identification of PP2A Complexes and Pathways Involved in Cell Transformation
- (2010) A. A. Sablina et al. CANCER RESEARCH
- c-Myc Regulates Transcriptional Pause Release
- (2010) Peter B. Rahl et al. CELL
- Suppression of Aurora-A oncogenic potential by c-Myc downregulation
- (2010) Shangbin Yang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics
- (2010) T. Macarulla et al. MOLECULAR CANCER THERAPEUTICS
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Inhibition of the Peptidyl-Prolyl-Isomerase Pin1 Enhances the Responses of Acute Myeloid Leukemia Cells to Retinoic Acid via Stabilization of RAR and PML-RAR
- (2009) M. Gianni' et al. CANCER RESEARCH
- Anticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
- (2009) D. Drygin et al. CANCER RESEARCH
- The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc
- (2009) Hugh K Arnold et al. EMBO JOURNAL
- Discovery and Development of Aurora Kinase Inhibitors as Anticancer Agents
- (2009) John R. Pollard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Formation of a Unique End-to-End Stacked Pair of G-Quadruplexes in the hTERT Core Promoter with Implications for Inhibition of Telomerase by G-Quadruplex-Interactive Ligands
- (2009) SunMi L. Palumbo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
- (2009) P. Hydbring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-molecule perturbation of competing interactions between c-Myc and Max
- (2008) Ariele Viacava Follis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins
- (2008) Hugh K. Arnold et al. CANCER AND METASTASIS REVIEWS
- Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc–Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
- (2008) Jianxia Guo et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Myc-Mediated Transcriptional Repression by Recruitment of Histone Deacetylase
- (2008) J. F. Kurland et al. CANCER RESEARCH
- Structural Rationale for the Coupled Binding and Unfolding of the c-Myc Oncoprotein by Small Molecules
- (2008) Ariele Viacava Follis et al. CHEMISTRY & BIOLOGY
- Myc's broad reach
- (2008) M. Eilers et al. GENES & DEVELOPMENT
- Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis
- (2008) Claudia Fila et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability
- (2008) Prudence B Lam et al. Molecular Cancer
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- Max-independent functions of Myc in Drosophila melanogaster
- (2008) Dominik Steiger et al. NATURE GENETICS
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started